{
    "Trade/Device Name(s)": [
        "Estrogen Receptor Clone 6F11 Ready-to-Use Primary Antibody for Bond",
        "Estrogen Receptor Clone 6F11 Liquid Concentrate Primary Antibody, Novocastra"
    ],
    "Submitter Information": "Leica Biosystems Newcastle, Ltd",
    "510(k) Number": "K122556",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060227"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MYA"
    ],
    "Summary Letter Date": "April 8, 2014",
    "Summary Letter Received Date": "April 10, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.1860"
    ],
    "Regulation Name(s)": [
        "Immunohistochemistry Reagents and Kits"
    ],
    "Analyte Class(es)": [
        "anatomic pathology"
    ],
    "Analyte(s)": [
        "Estrogen receptor"
    ],
    "Specimen Type(s)": [
        "Formalin-fixed, paraffin-embedded breast cancer tissue"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Leica Biosystems Bond II",
        "Leica Biosystems Bond III automated slide staining system"
    ],
    "Method(s)/Technology(ies)": [
        "Immunohistochemistry (IHC)"
    ],
    "Methodologies": [
        "Qualitative antigen detection by light microscopy",
        "Polymer detection system"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Antibody"
    ],
    "Document Summary": "FDA 510(k) summary for Estrogen Receptor Clone 6F11 antibodies for IHC detection of ER in breast cancer tissues using Leica Bond platforms",
    "Indications for Use Summary": "Qualitative identification of estrogen receptor antigen in formalin-fixed, paraffin-embedded breast cancer tissue sections by immunohistochemistry, as an aid in the management, prognosis, and prediction of therapy outcome of breast cancer.",
    "fda_folder": "Hematology"
}